FDA grants breakthrough device designation to new AAA sealing system

Michael Walter | | Cardiovascular Business | Vascular & Endovascular
Abdominal aortic aneurysm

Endologix, a California-based healthcare technology company, announced July 19 that its Chevas (Chimney Endovascular Aneurysm Sealing) system for abdominal aortic aneurysm (AAA) patients has received the FDA’s breakthrough device designation.

The new solution combines the company’s Nellix 3.5 endograft with parallel visceral stents for the treatment of juxtarenal, pararenal and suprarenal AAA. It is currently being evaluated in the ongoing Chevas One investigational device exemption (IDE) clinical study.

“The aneurysm sac sealing technology featured in the Chevas system is designed to reduce endoleaks, including gutter endoleaks, that are reported after endovascular treatment of complex aneurysms,” James McKinsey, MD, the leading enroller for the Chevas One IDE study, said in a statement. “Our initial clinical results of this therapy have been promising in a challenging group of patients.”

McKinsey is scheduled to present findings from the trial at the Eastern Vascular Society Annual Meeting on Sept. 26.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

IVUS-guided PCI reduces risks in patients with diabetes
LAAC with Watchman FLX reduces bleeding risks after AFib ablation
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Shockwave Medical’s IVL technology delivers more positive outcomes for PAD patients
Standing desks fail to lower blood pressure or minimize heart risks—they may even do damage
IVL vs. RA for chronic total occlusion PCI: Key data cardiologists should know

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."